Tamoxifen for women at high risk of breast cancer

References

• BrownKBreast cancer chemoprevention: risk-benefit effects of the anti-oestrogen tamoxifenExpert Opin Drug Saf2002125326712904141
   PubMedGoogle Scholar
• Early Breast Cancer Trialists Collaborative GroupEffects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsLancet20053651687171715894097
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists Collaborative GroupTamoxifen for early breast cancer: an overview of the randomized trialsLancet1998351145114679605801
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care ExcellenceMajor shift in breast cancer care on horizon as NICE recommends preventative drugs for ‘at-risk’ women Available from: http://www.nice.org.uk/newsroom/pressreleases/NICERecommendsBreastCancerdrugs.jspAccessed November 27, 2013
   Google Scholar
• HigginsMJStearnsVCYP2D6 polymorphisms and tamoxifen metabolism: clinical relevanceCurr Oncol Rep20101271520425602
   PubMed Web of Science ®Google Scholar
• FisherBCostantinoJPWickerhamDLTamoxifen for prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJ Natl Cancer Inst2005971652166216288118
   PubMed Web of Science ®Google Scholar
• NayfieldSGKarpJEFordLGPotential role of tamoxifen in prevention of breast cancerJ Natl Cancer Inst199183145014591920492
   PubMed Web of Science ®Google Scholar
• PowlesTJAshleySTidyATwenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trialJ Natl Cancer Inst20079928329017312305
   PubMed Web of Science ®Google Scholar
• CuzickJForbesJFSestakILong-term results of tamoxifen prophylaxis for breast cancer – 96-month follow-up of the randomized IBIS-I trialJ Natl Cancer Inst20079927228217312304
   PubMed Web of Science ®Google Scholar
• VeronesiUMaisonneuvePRotmenszNTamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial Among Women With HysterectomyJ Natl Cancer Inst20079972773717470740
   PubMed Web of Science ®Google Scholar
• NarodSABRCA mutations in the management of breast cancer: the state of the artNat Rev Clin Oncol2010770270720956982
   PubMed Web of Science ®Google Scholar
• GronwaldJTungNFoulkesWDHereditary Breast Cancer Clinical Study GroupTamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an updateInt J Cancer20061182281228416331614
   PubMed Web of Science ®Google Scholar
• MetcalfeKLynchHGhadirianPContralateral breast cancer in BRCA1 and BRCA2 mutation carriersJ Clin Oncol2004222328233515197194
   PubMed Web of Science ®Google Scholar
• PhillipsKAMilneRRookusMTamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriersJ Clin Oncol2013313091309923918944
   PubMed Web of Science ®Google Scholar
• KingMCWieandSHaleKNational Surgical Adjuvant Breast and Bowel ProjectTamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2JAMA20012862251225611710890
   PubMed Web of Science ®Google Scholar
• WhiffenAEl-TamerMTabackBFeldmanSJosephKAPredictors of breast cancer development in women with atypical ductal hyperplasia and atypical lobular hyperplasiaAnn Surg Oncol20111846346720878246
   PubMed Web of Science ®Google Scholar
• CoopeySBMazzolaEBuckleyJMThe role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesionsBreast Cancer Res Treat201213662763323117858
   PubMed Web of Science ®Google Scholar
• CuzickJWarwickJPinneyETamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control studyJ Natl Cancer Inst201110374475221483019
   PubMed Web of Science ®Google Scholar
• ChenJ-HChangeY-CChangDReduction of breast density following tamoxifen treatment evaluated by 3-D MRI: preliminary studyMagn Reson Imaging201129919820832226
   PubMed Web of Science ®Google Scholar
• IqbalJGinsburgOMWijeratneTDEndometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic reviewCancer Treat Rev20123831832821775065
   PubMed Web of Science ®Google Scholar
• SmithLLBrownKCarthewPChemoprevention of breast cancer by tamoxifen: risks and opportunitiesCrit Rev Toxicol20003057159411055836
   PubMed Web of Science ®Google Scholar
• KaplanCPKimSEWongSTSawayaGFWalshJMPérez-StableEJWillingness to use tamoxifen to prevent breast cancer among diverse womenBreast Cancer Res Treat201213335736622315131
   PubMed Web of Science ®Google Scholar
• LinJHZhangSMMansonJEPredicting adherence to tamoxifen for breast cancer adjuvant therapy and preventionCancer Prev Res2011413601365
   PubMed Web of Science ®Google Scholar
• ArmstrongKQuistbergDAMiccoEPrescription of tamoxifen for breast cancer prevention by primary care physiciansArch Intern Med20061662260226517101945
   PubMedGoogle Scholar
• VogelVGCostantinoJPWickerhamDLUpdate of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 trial: preventing breast cancerCancer Prev Res (Phila)2010369670620404000
   PubMed Web of Science ®Google Scholar
• VisvanathanKHurleyPBantugEUse of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guidelineJ Clin Oncol2013312942296223835710
   PubMed Web of Science ®Google Scholar
• GossPEIngleJNAles-MartinezJEExemestane for breast-cancer prevention in postmenopausal womenN Engl J Med20113642381239121639806
   PubMed Web of Science ®Google Scholar
• Van de VeldeCJReaDSeynaeveCAdjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomized phase 3 trialLancet201137732133121247627
   PubMed Web of Science ®Google Scholar
• LazzeroniMSerranoDDunnBKOral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drugBreast Cancer Res20121421423106852
   PubMed Web of Science ®Google Scholar
• DecensiABonanniBGuerrieri-GonzagaABiologic activity of tamoxifen at low doses in healthy womenJ Natl Cancer Inst199890146114679776411
   PubMed Web of Science ®Google Scholar
• DecensiARobertsonCGuerrieri-GonzagaARandomized double-blind 2 × 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal womenJ Clin Oncol2009273749375619597031
   PubMed Web of Science ®Google Scholar
• AlknerSBendahlP-OFernoMTamoxifen reduces the risk of contralateral breast cancer in premenopausal women: results from a controlled randomised trialEur J Cancer2009452496250219535242
   PubMed Web of Science ®Google Scholar
• RouanetPLinares-CruzGDravetFNeoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifenJ Clin Oncol2005232980298715860853
   PubMed Web of Science ®Google Scholar